Join the 'Intrarosa' group to help and get support from people like you.
Posted 29 Aug 2017 by Drugs.com
TUESDAY, Aug. 29, 2017 – Parents often try unconventional treatments – such as acupuncture and herbal products – when their kids are sick, but many don't tell their pediatricians about it, a new report shows. Such omissions could be risky, especially when these young patients are already taking traditional medications, the report authors said. "The point we're making in this report is that many of our young patients are already using these [complementary] therapies," said lead author Dr. Hilary McClafferty. "And much of that use is driven by the consumer, by parents looking for additional help for their children. "But a lot of parents are not necessarily disclosing this use to their child's pediatrician, for fear of censure or ridicule," McClafferty explained. "That can be a problem, because while we are really excited about some of the advances in the field of complementary medicine ... Read more
Related support groups: Melatonin, Fish Oil, Lovaza, Vitamin/Mineral Supplementation and Deficiency, Glucosamine, Herbal Supplementation, 5-HTP, Acidophilus, Turmeric, Cranberry, Garlic, Chondroitin, Creatine, Green Tea, Valerian, St. John's Wort, Lysine, Tryptophan, Milk Thistle, Evening Primrose
Posted 22 Nov 2016 by Drugs.com
November 17, 2016 – The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA). During menopause, levels of estrogen decline in vaginal tissues, which may cause a condition known as VVA, leading to symptoms such as pain during sexual intercourse. “Pain during sexual intercourse is one of the most frequent symptoms of VVA reported by postmenopausal women,” said Audrey Gassman, M.D., deputy director of the Division of Bone, Reproductive, and Urologic Products (DBRUP) in the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research (CDER). “Intrarosa provide ... Read more